2023
Body mass index and obesity-related behaviors in African American church-based networks: A social network analysis
Nam S, Jung S, Vlahov D, Latkin C, Kershaw T, Whittemore R. Body mass index and obesity-related behaviors in African American church-based networks: A social network analysis. PLOS ONE 2023, 18: e0281145. PMID: 36913354, PMCID: PMC10010537, DOI: 10.1371/journal.pone.0281145.Peer-Reviewed Original Research
2003
Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort
Bernstein K, Jacobson L, Jenkins F, Vlahov D, Armenian H. Factors Associated With Human Herpesvirus Type 8 Infection in an Injecting Drug User Cohort. Sexually Transmitted Diseases 2003, 30: 199-204. PMID: 12616135, DOI: 10.1097/00007435-200303000-00004.Peer-Reviewed Original ResearchConceptsHHV-8 seroprevalenceRisk factorsHHV-8Human herpesvirus type 8 infectionLarger body mass indexHuman herpesvirus type 8Drug user cohortHHV-8 seropositivityInjection drug useBody mass indexMultivariate logistic regressionCross-sectional studyDrug user populationGenital wartsMass indexGeneral populationDrug useSeroprevalenceIndirect immunofluorescenceLogistic regressionIDUsInfectionType 8User cohortSexual behavior
2002
Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users
Semba R, Shah N, Vlahov D. Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users. International Journal Of STD & AIDS 2002, 13: 119-123. PMID: 11839167, DOI: 10.1258/0956462021924758.Peer-Reviewed Original ResearchConceptsInjection drug usersCumulative incidenceRisk factorsDrug usersMycobacterium avium complex infectionHigher body mass indexBody mass indexLongitudinal cohort studyZidovudine useCohort studyLymphocyte countOral thrushMass indexComplex infectionFemale genderHigh riskLower riskAnemiaMicrocytic anemiaIncidenceWeight lossCells/Marijuana useRiskCD4
2001
Improvement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy
Semba R, Shah N, Vlahov D. Improvement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 315-319. PMID: 11317071, DOI: 10.1097/00126334-200104010-00003.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAnemiaAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBaltimoreBody Mass IndexCD4 Lymphocyte CountChronic DiseaseFemaleHemoglobinsHIV InfectionsHIV-1HumansLongitudinal StudiesMaleMultivariate AnalysisPrevalenceSex FactorsSubstance Abuse, IntravenousViral LoadConceptsInjection drug usersPlasma HIV loadActive antiretroviral therapyAntiretroviral therapyHIV loadOpportunistic infectionsCopies/Mean decreaseDrug usersHIV-positive injection drug usersPotent antiretroviral therapyImprovement of anemiaBody mass indexIncrease of hemoglobinAntiretroviral medicationsHIV infectionMass indexControl subjectsOverall prevalenceChronic diseasesAnemiaNutritional statusMean increaseMultivariate analysisHAART
1999
Comparison of Clinical Manifestations of HIV Infection Among Women by Risk Group, CD4+ Cell Count, and HIV-1 Plasma Viral Load
Rompalo A, Astemborski J, Schoenbaum E, Schuman P, Carpenter C, Holmberg S, Warren D, Farzadegan H, Vlahov D, Smith D. Comparison of Clinical Manifestations of HIV Infection Among Women by Risk Group, CD4+ Cell Count, and HIV-1 Plasma Viral Load. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 448-454. PMID: 10225226, DOI: 10.1097/00042560-199904150-00006.Peer-Reviewed Original ResearchConceptsHIV-1 viral loadPlasma viral loadBody mass indexHIV-1 plasma viral loadOral hairy leukoplakiaInjection drug useViral loadInjection drug usersRisk groupsHIV infectionCell countDrug useHairy leukoplakiaCells/Clinical manifestationsHeterosexual contactMedian HIV-1 viral loadPlasma HIV-1 viral loadUndetectable HIV-1 viral loadPlasma viral load levelsHIV viral loadIntravenous drug useViral load levelsPopulation of HIVPrevalence of HIV
1995
Vitamin A Deficiency and Wasting as Predictors of Mortality in Human Immunodeficiency Virus-Infected Injection Drug Users
Semba R, Caiaffa W, Graham N, Cohn S, Vlahov D. Vitamin A Deficiency and Wasting as Predictors of Mortality in Human Immunodeficiency Virus-Infected Injection Drug Users. The Journal Of Infectious Diseases 1995, 171: 1196-1202. PMID: 7751694, DOI: 10.1093/infdis/171.5.1196.Peer-Reviewed Original ResearchConceptsInjection drug usersHuman immunodeficiency virus-infected injection drug usersDrug usersPredictors of mortalityLarge prospective cohortBody mass indexHuman immunodeficiency virusCase-control studyPlasma vitamin ACD4 cellsProspective cohortHIV infectionIndependent predictorsMass indexImmunodeficiency virusLast visitRisk factorsHigh riskVitamin AAdult subjectsMortalityInfectionMean lengthWastingVitamin